GSK Transfers Levitra® Co-Promotion Rights Back to Bayer
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 56 (Table of Contents)
Published: 5 Feb-2005
DOI: 10.3833/pdr.v2005.i56.730 ISSN: 1756-7874
Section: Distribution & Marketing
Fulltext:
Abstract
GlaxoSmithKline (GSK) is to sell the marketing rights of Levitra® (vardenafil), a male impotence drug back to Bayer for €208 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS